Literature DB >> 11927166

Lamotrigine increases gene expression of GABA-A receptor beta3 subunit in primary cultured rat hippocampus cells.

Jun Feng Wang1, Xiujun Sun, Biao Chen, L Trevor Young.   

Abstract

To study the mechanism of action of the novel anticonvulsant and mood stabilizer lamotrigine, we used cDNA array to generate an expression profile of lamotrigine-regulated genes in primary cultured rat hippocampus cells. Gene expression was analyzed using Atlas Rat 1.2 Arrays of approximately 1200 genes. Total RNA was isolated from control and cells treated with lamotrigine at 0.1 mM for one week and reverse-transcribed to cDNA labeled with 32P-dATP. The cDNA probes were hybridized with two identical cDNA array membranes. After comparing hybridized signals between these two membranes, we found that chronic treatment with lamotrigine increased the expression of eight genes and decreased the expression of six genes. One of the upregulated genes is GABA-A receptor beta subunit. This increase in GABA-A receptor beta3 subunit expression was further confirmed by Northern blotting analysis. In situ hybridization revealed that chronic treatment with lamotrigine increased GABA-A receptor beta3 subunit gene expression in CA1, CA3 and dentate gyrus of rat hippocampus. Our findings indicate that lamotrigine may effect GABA-A receptor regulated functions in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927166     DOI: 10.1016/S0893-133X(01)00385-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  5 in total

1.  Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder.

Authors:  Thalia K Robakis; Jessie Holtzman; Pascale G Stemmle; Margaret F Reynolds-May; Heather A Kenna; Natalie L Rasgon
Journal:  J Affect Disord       Date:  2014-12-24       Impact factor: 4.839

Review 2.  Epilepsy in Angelman syndrome: A scoping review.

Authors:  Debopam Samanta
Journal:  Brain Dev       Date:  2020-09-04       Impact factor: 1.961

3.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

4.  Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.

Authors:  Martin Begemann; Derya Sargin; Moritz J Rossner; Claudia Bartels; Fabian Theis; Sven P Wichert; Nike Stender; Benjamin Fischer; Swetlana Sperling; Sabina Stawicki; Anne Wiedl; Peter Falkai; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 5.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.